Mark Wade
Impact in
-
- Cancer Genomics and Diagnostics
Papers in
-
- Histone Deacetylase Inhibitors Research 3
- Epigenetics and DNA Methylation 3
- Molecular Biology Techniques and Applications 3
- Oncology 10
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- F.A. Fitzpatrick (4 shared papers)Kenneth M. Boucher (9 shared papers)Pamela B. Cassidy (3 shared papers)Sunil Sharma (6 shared papers)Ali Keshavarzian (1 shared paper)A. Banan (1 shared paper)Stephen Bocckino (1 shared paper)Brian J. Day (1 shared paper)
- Journals
- Investigational New Drugs (4 papers)Journal of Clinical Oncology (4 papers)Cancer Research (4 papers)Annals of Oncology (3 papers)Archives of Biochemistry and Biophysics (2 papers)
- Partner nations
- United StatesSwitzerlandCuba
In The Last Decade
Mark Wade
34 papers receiving 617 citations
Peers
Comparison fields: 5 of 90
- Oncology 150
- Cancer Research 80
- Genetics 51
- Biochemistry 34
- Immunology 98
Countries citing papers authored by Mark Wade
This map shows the geographic impact of Mark Wade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wade more than expected).
Fields of papers citing papers by Mark Wade
This network shows the impact of papers produced by Mark Wade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wade. The network helps show where Mark Wade may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Wade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 114 | |
| 2 | 2001 | 80 | |
| 3 | 2011 | 75 | |
| 4 | 2013 | 56 | |
| 5 | 2014 | 46 | |
| 6 | 2009 | 34 | |
| 7 | 1997 | 33 | |
| 8 | 2004 | 29 | |
| 9 | 1995 | 23 | |
| 10 | 2018 | 17 | |
| 11 | 2015 | 14 | |
| 12 | 2009 | 14 | |
| 13 | 2016 | 13 | |
| 14 | 2016 | 10 | |
| 15 | 2003 | 7 | |
| 16 | 2003 | 7 | |
| 17 | 2017 | 7 | |
| 18 | 2020 | 7 | |
| 19 | 2003 | 7 | |
| 20 | 2019 | 6 |
About Mark Wade
Mark Wade is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 35 papers that have together received 632 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Cancer Mechanisms and Therapy (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Phagocytosis and Immune Regulation (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Epigenetics and DNA Methylation (3 papers), Molecular Biology Techniques and Applications (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (150 citations), Cancer Research (80 citations), Genetics (51 citations), Biochemistry (34 citations) and Immunology (98 citations). Mark Wade has collaborated with scholars based in United States, Switzerland and Cuba. Frequent co-authors include F.A. Fitzpatrick, Kenneth M. Boucher, Pamela B. Cassidy, Sunil Sharma, Ali Keshavarzian, A. Banan, Stephen Bocckino, Brian J. Day, S. Choudhary and Wolfram E. Samlowski. Their work appears in journals such as Investigational New Drugs, Journal of Clinical Oncology, Cancer Research, Annals of Oncology and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.